en · de · es · fr · pt
tb-500-notes.peptides6908.com › Blog › Thymosin Beta-4 Fragment Overview — Quick Reference

Thymosin Beta-4 Fragment Overview — Quick Reference

By Editorial Desk · published 2025-08-19 · last reviewed 2025-10-07 · Blog

Everything below concerns TB-500. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Updated 2025-10-07. Numbers and descriptions here follow the published literature rather than marketing material.

Thymosin Beta-4 Fragment Overview

The compound circulates in the literature as a research reagent rather than an approved therapeutic. Regulatory agencies in several countries have not authorized it for medical use, and sporting bodies list related thymosin beta-4 peptides among prohibited substances. Suppliers typically market it with a purity figure and a certificate of analysis, while peer-reviewed clinical reports remain sparse. Discussions therefore often separate laboratory findings from anecdotal reports, and reviewers tend to note the small size and methodological limits of the available studies.

TB-500 refers to a synthetic peptide fragment derived from the actin-binding region of thymosin beta-4, a protein present in most mammalian cells. The full protein contains forty-three amino acids, while the commonly sold fragment is a much shorter acetylated sequence, often cited as LKKTETQ. The fragment retains part of the actin-binding motif but lacks the remainder of the parent protein. Material sold under this name is usually lyophilized powder intended for laboratory research, and it is not a finished pharmaceutical product.

Proposed activity centers on actin sequestration and on the movement of cells during repair processes. In cell culture and animal models, the fragment has been associated with migration, tube formation, and tissue remodeling. These observations are frequently described as preliminary, because most published work uses rodent or in vitro systems rather than controlled human trials. Whether the short fragment reproduces the effects of the full protein remains an open question, and the relationship between dose, route, and measured outcome is not well characterized.

Identification and Molecular Background

Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.

Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.

TB-500 is a synthetic peptide whose sequence corresponds to a short fragment near the N-terminus of thymosin beta-4, a small protein present in most mammalian cells. The fragment is commonly cited as containing the actin-binding region of the parent molecule, which is why it appears in laboratory work on cell migration and tissue repair. Suppliers distribute it as a lyophilised powder intended for research use. Its identity is defined by amino acid sequence and by the presence of an acetyl group on the N-terminal residue.

Tb-500 at a glance

PropertyValueNotes
AppearanceWhite to off-white powderLyophilized solid as supplied
Water solubilitySolubleDissolves in aqueous media
Typical storage temperature-20 °CDry powder, desiccated, protected from light
Typical analytical methodRP-HPLC with mass spectrometryPurity from peak area; mass for identity
Common synonymsTβ4 fragment; thymosin beta-4 fragmentNaming varies by supplier and catalogue

Storage, Handling, and Analytical Checks

The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.

Lyophilized peptide powder is normally held desiccated at −20 °C, with −80 °C used for longer storage periods. Allowing a sealed vial to reach room temperature before opening is standard practice, because condensation forming on cold powder introduces moisture. Once dissolved, solutions are typically kept cold and shielded from light. Repeated freeze-thaw cycles are avoided because they encourage aggregation and gradual loss of material. These conventions are general to synthetic peptides rather than unique to any one sequence.

Related pages on this site

Storage and Analytical Verification

Dry powder is commonly held at minus twenty degrees Celsius, with some suppliers recommending lower temperatures for long-term archival storage. Once dissolved, solutions are typically kept cold and protected from light, since aqueous peptide solutions can lose integrity through hydrolysis or oxidation over time. Stability data specific to this fragment are limited in the public literature, and much of the guidance comes from general peptide handling practice rather than from controlled degradation studies. Users therefore treat stated shelf lives as approximate rather than fixed.

Identity and purity are normally assessed with reversed-phase high-performance liquid chromatography, paired with mass spectrometry to confirm molecular mass. A certificate of analysis reports a purity percentage, usually derived from chromatographic peak area, but that figure does not by itself prove a correct sequence or the absence of counterions. Independent verification may include amino acid analysis or peptide mapping. Batch-to-batch variation is a documented concern in the research chemical market, and the gap between a quoted purity value and actual peptide content can be substantial when the material is a salt or retains residual water.

Detection, Stability, and Regulatory Status

Sports authorities classify the peptide as a prohibited substance, and it appears on the World Anti-Doping Agency list under peptide hormones, growth factors, and related substances. Racing jurisdictions for horses and dogs have issued separate restrictions, and several national bodies treat it as a controlled or prescription-only item. As a research chemical it is sold without a therapeutic indication, and labels usually state that the product is not for human or veterinary use. Regulatory treatment therefore varies by country.

Detection in biological matrices generally relies on liquid chromatography coupled with tandem mass spectrometry, because the peptide lacks a convenient ultraviolet chromophore beyond the amide backbone. Immunoassays have been described, but antibodies raised against the fragment can cross-react with the full-length protein or with unrelated peptides, so findings usually require confirmation by a second technique. Sample preparation typically involves protein precipitation followed by solid-phase extraction. Reported detection windows depend on dose, route, matrix, and instrument sensitivity.

TB-500 Identity and Naming Background

Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.

TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.

Further detail

Rosiglitazone is a member of the thiazolidinedione class of drugs. Thiazolidinediones act as insulin sensitizers. They reduce glucose, fatty acid, and insulin blood concentrations. They work by binding to the peroxisome proliferator-activated receptors (PPARs). PPARs are transcription factors that reside in the nucleus and become activated by ligands such as thiazolidinediones. Thiazolidinediones enter the cell, bind to the nuclear receptors, and alter the expression of genes. The several PPARs include PPARα, PPARβ/δ, and PPARγ. Thiazolidinediones bind to PPARγ. PPARs are expressed in fat cells, cells of the liver, muscle, heart, and inner wall (endothelium) and smooth muscle of blood vessels. PPARγ is expressed mainly in fat tissue, where it regulates genes involved in fat cell (adipocyte) differentiation, fatty acid uptake and storage, and glucose uptake. It is also found in pancreatic beta cells, vascular endothelium, and macrophages Rosiglitazone is a selective ligand of PPARγ and has no PPARα-binding action. Other drugs bind to PPARα. Rosiglitazone also appears to have an anti-inflammatory effect in addition to its effect on insulin resistance. Nuclear factor kappa-B (NF-κB), a signaling molecule, stimulates the inflammatory pathways. NF-κB inhibitor (IκB) downregulates the inflammatory pathways. When patients take rosiglitazone, NF-κB levels fall and IκB levels increase.

=== Gastropods === Achatina fulica, giant African snail (2019) Biomphalaria glabrata, a medically important air-breathing freshwater snail in the family Planorbidae (2017) Biomphalaria straminea, Ramshorn snail (2022) Candidula unifasciata, Land snail (2021) Conus ventricosus, Mediterranean cone snail (2021) Elysia chlorotica, a solar-powered sea slug (2019) Haliotis discus hannai, pacific abalone (2017) Kalloconus canariensis, Canary Island cone shell (2023) Kelletia kelletii, Kellet's whelk (2023) Lottia gigantea, owl limpet (2013) Plakobranchus ocellatus, Kleptoplastic sea slug (2021) Pomacea canaliculata, golden apple snail (2018) Littorina brevicula, periwinkle snail (2024) Littoraria sinensis (2024)

==== Other optical imaging ==== For in vivo fluorescence-based optical imaging, dyes that emit near infrared (NIR) wavelengths >700 nm are most effective, such as indocyanine green, but encounter limitations with reduced circulation time and nonspecific interactions with other biological factors that affect the fluorescence. pH-sensitive nanogels with functionalized surface receptors to target cancer cells were loaded with a fluorescent dye that was only released upon endocytosis. These nanogels successfully generated a fluorescent signal from within the cancer cells and many other groups have developed similar technologies.

== Types == Baked Alaska is a bombe which is baked, frozen and flambéed. The Italian dessert spumoni is shaped as a bombe with a semifreddo or parfait filling and custard ice cream forming the outside layer. The watermelon bombe is three layered with green-tinted ice cream on the outside, with a thin layer of white ice cream and a red inside layer with chocolate chips. Nesselrode pudding is a thick custard cream that is molded and served as a bombe with maraschino custard sauce. The custard is made with sweetened chestnut puree, dried fruits, cherry liquor and whipped cream. In Victorian cuisine Creme à la Moscovite was a partially frozen ice set with isinglass (or gelatin), similar to bavarois.

Sources: en.wikipedia.org

Background from the literature

The number of unique protein species likely will increase by between 50,000 and 500,000 due to RNA splicing and proteolysis events, and when post-translational modification also are considered, the total number of unique human proteins is estimated to range in the low millions. In addition, the first promising attempts to decipher the proteome of animal tumors have recently been reported. This method was used as a functional method in Macrobrachium rosenbergii protein profiling.

The fact that UV-B radiation (Dorno radiation, after Carl Dorno (1865-1942)) is a proven carcinogen, but is also required for the body's own synthesis of vitamin-D3 (cholecalciferol), leads to internationally conflicting recommendations regarding health-promoting UV exposure. In 2014, based on the scientific evidence of the last decades, 20 scientific authorities, professional societies and associations from the fields of radiation protection, health, risk assessment, medicine and nutrition published a recommendation on "UV exposure for the formation of the body's own vitamin D". It was the first interdisciplinary recommendation on this topic worldwide. Using a solarium for the first time at a young age (<35 years) almost doubles the risk of developing malignant melanoma. In Germany, the use of tanning beds by minors has been prohibited by law since March 2010. As of August 1, 2012, sunbeds must not exceed a maximum irradiance of 0.3 watts per square meter of skin. Sunbeds must be labeled accordingly. The new irradiance limit corresponds to the highest UV dose that can be measured on Earth at 12 noon under a cloudless sky at the equator. The minimum erythema dose (MED) is determined for medical applications. The MED is defined as the lowest dose of radiation that produces a barely visible erythema. It is determined 24 hours after the test irradiation. It is performed with the type of lamp intended for the therapy by applying so-called light stairs to skin that is not normally exposed to light (for example, on the buttocks).

=== Molecular Separations === The well-defined pore structure of organic cages enables selective molecular separations. Molecular cages can discriminate between molecules based on size, shape, and chemical affinity. Gas separation represents a major application, where cages are incorporated into mixed-matrix membranes for selective gas transport. Studies have demonstrated effective separation of CO2/N2, CO2/CH4, and other industrially relevant gas mixtures. The uniform pore size and chemical environment ensure consistent separation performance. In liquid-phase separations, organic cages show promise for challenging molecular separations. Their solution processability enables incorporation into chromatographic stationary phases. The intrinsic chirality of some cage structures allows for enantioselective separations of racemic mixtures, achieving high separation factors for pharmaceutical and fine chemical applications.

== Production capacity == Grameen Danone has planned to set up and launch as many as 50 production plants during the ten years between 2006 and 2016. The first factory has been built in Bogra district which is about 230 kilometres (140 mi) north of Dhaka, the capital city of Bangladesh. The first factory is a small one built upon an area of 7,000 sq ft (650 m2). Its daily production capacity was 3,000 kilograms (6,600 lb) of yogurt when launched in 2006. In 2008, the production capacity has been planned to be enhanced to 10,000 kilograms (22,000 lb) and beyond. Several hundred livestock-farming and distribution jobs would be created in the local community as a result of establishment of the first factory. As of 2011, the company had not opened another factory.

=== Ukraine === The Armed Forces of Ukraine's combat ration was based on a previous Russian version, consisting of commercially available cans and dried foods packed together in a sectioned box (resembles a takeout tray) made of very thin green plastic. Inside were: two 250 g mmin meal cans (boiled buckwheat groats and buckwheat w/beef); two 100 g cans of meat spread (liver pâté and beef in lard); a 160 g can of herring or mackerel; six 50 g packages small, hard crackers (resemble oyster crackers); two foil pouches (20 g each) of jam or jelly; six boiled sweets two tea bags; an envelope of instant cherry juice powder; a chicken flavour bouillon cube; two packets of sugar; and three dining packets, each with a plastic spoon, a napkin, and a moist towelette. In 2018, the Ukrainian military improved their ration contents to be more in line with NATO standards, with different menus for each day in a week. By the Russian invasion of Ukraine, according to a BBC News correspondent who received a field ration from a Ukrainian soldier, the contents of a typical Ukrainian field rations included "wheat porridge with beef; rice and meat soup; beef stew; chicken with vegetables; pork and vegetables; crackers; biscuits; tea bags; coffee; blackcurrant drink; honey; sugar; black pepper; chewing gum; bar of dark chocolate; plastic spoons; [and] moist wipes".

Sources: en.wikipedia.org

Reference notes

==== 1952–53 ==== When he joined the Cardinals, broadcaster Harry Caray started calling him "Vinegar Bend," and the nickname stuck. He was hailed as "the left-handed Dizzy Dean" by sportswriter Red Smith, which Mizell called "a perty heavy load for a boy to tote." Added to St. Louis's starting rotation for the 1952 campaign, Mizell made his major league debut on April 22 against the Cincinnati Reds. He gave up two runs in the first inning, then held the Reds scoreless for the rest of the game, though he took the loss in a 2–1 defeat. Two starts later, on May 2, he limited the Philadelphia Phillies to four hits and two runs in a complete game, winning in the ninth when Peanuts Lowrey broke a 2–2 tie with an RBI-single. After that win, he lost three games in a row, then received four consecutive no decisions. He ended the winless streak on June 21, when he struck out 11 in his first major league shutout against the Boston Braves. That started a streak of six decisions won in a row, during which time Mizell posted a 3.05 ERA. He would not lose again until August 27. On September 5, he threw his second shutout of the year, tying his season high with 11 strikeouts in a 4–0 victory over the Pittsburgh Pirates. Mizell finished his rookie season with a 10–8 record and a 3.65 ERA in 30 starts. He led the National League (NL) in strikeouts per 9 innings pitched with a 6.9 mark, and his 146 strikeouts ranked fourth in the league (behind Warren Spahn's 183, Bob Rush's 157, and Robin Roberts's 148). However, he also led the league in walks (103, tied with Herm Wehmeier).

This finding seems to indicate that merely encountering a religious belief system such as Buddhism may allow some of its effects to be transferred to nonbelievers. However, many disagree that the benefits the religious experience are due to their beliefs, and some find there to be no conclusive psychological benefits of belief at all. For example, the health benefit that the elderly gain from going to church may in fact be the reason they are able to go to church; the less healthy cannot leave their homes. Meta analysis has found that find studies purporting the beneficial results of religiosity often fail to fully represent data correctly due to a number of issues such as self-report bias, the use of inappropriate comparison groups, and the presence of criterion contamination. Other studies have disputed the efficacy of intercessory prayer positively affecting the health of those being prayed for. They have shown that, when scientifically rigorous studies are performed (by randomizing the patients and preventing them from knowing that they are being prayed for), there is no discernible effect. Religion has power as a cohesive social force, and whether or not it is always beneficial is debated. Irrespective of a group's beliefs, many find that simply belonging to a tight social group reduces anxiety and mental health problems. In addition, there may be a degree of self-selectivity amongst the religious; the behavioral benefits they display may simply be common aspects of those who choose to or are able to practice religion.

His rare non-comedic film roles include two collaborations with Andre Gregory and Louis Malle: the semi-autobiographical dialogue My Dinner with Andre, and a combined production-and-backstage-drama of Uncle Vanya titled Vanya on 42nd Street. Shawn quite often appears on television, where he has appeared in many genres and series. He has had recurring roles as the Grand Nagus Zek on Star Trek: Deep Space Nine, Stuart Best on Murphy Brown, Jeff Engels on The Cosby Show, Dr. Howard Stiles on Crossing Jordan, Arnie Ross on Taxi, Charles Lester on both The Good Wife and The Good Fight, a reprisal of his role as Mr. Hall on Clueless (based on the film), and Father Frank Ignatius on Evil. He appeared in the 1985 music video for Chaka Khan's "This Is My Night". On February 4, 2010, Shawn appeared as Alan Rubin on The Daily Show with Jon Stewart. A Master Builder opened in New York City in June 2014. In 2018, he joined the cast of Young Sheldon in the recurring role of Meemaw's boyfriend and Sheldon's physics professor, Dr. John Sturgis. Shawn starred in Woody Allen's 2020 film Rifkin's Festival, set in San Sebastián, Spain. Shawn was honored in 2005 with the PEN/Laura Pels International Foundation for Theater Award as a Master American Dramatist.

A ceasefire was reached between Israel and Hezbollah at the end of the 2006 Lebanon War, based on the terms of UN Security Council Resolution 1701 which called for a demilitarized zone between the southern border of Lebanon and the Litani river. The UN Security Council resolution mandated only the Lebanese army and United Nations Interim Force in Lebanon (UNIFIL) could be armed in southern Lebanon. It also stated that neither side should cross the Blue Line, which marks the border between Lebanon and the Golan Heights, and divides the village of Ghajar between the two. Despite this, both Israel and Hezbollah have outstanding obligations under UNSCR 1701. Since 2006, Hezbollah fortified southern Lebanon, obstructed UNIFIL's access, built tunnels into Israel, and crossed the Blue Line. Israel has also accused Hezbollah of using a local environmental organization as a front for its military activities near the Blue Line. After retreating behind the Blue Line in 2000, Israel reoccupied the whole of Ghajar in 2006, including the Lebanese part of the village. Israel continues to occupy Ghajar and an adjacent area, and has repeatedly breached Lebanese airspace, waters, and borders. UNIFIL reports that Israel entered Lebanese airspace on more than 22,000 occasions between 2007 and 2021.

Sources: en.wikipedia.org

Frequently asked questions

What is TB-500?

TB-500 is a name used for a short synthetic peptide fragment taken from the actin-binding region of thymosin beta-4. Material sold under this label is usually a lyophilized powder supplied for laboratory research rather than a licensed medicine. The commonly cited sequence is LKKTETQ.

How does it differ from full thymosin beta-4?

The parent protein contains forty-three amino acids, while the fragment carries only a short motif from one region. The fragment can interact with actin in vitro, but it does not include the rest of the protein structure. Whether the shorter molecule behaves the same way in living systems is not settled.

Is human evidence available?

Published controlled human studies are scarce, and most activity reports come from cell culture or animal models. Reviews often describe the evidence base as limited and methodologically uneven. Open questions include the relationship between route, dose, and measured outcomes.

What is TB-500 chemically?

It is a synthetic peptide based on a short sequence near the start of thymosin beta-4. It is supplied as a research chemical rather than as a licensed pharmaceutical product.

Network